We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

54 hedge funds and large institutions have $35.5M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

2% more funds holding

Funds holding: 53 → 54 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

21% less capital invested

Capital invested by funds: $45.1M → $35.5M (-$9.57M)

85% less call options, than puts

Call options by funds: $191K | Put options by funds: $1.31M

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
19
Reduced
11
Closed
11
Calls
$191K
Puts
$1.31M
Net Calls
-$1.12M
Net Calls Change
+$448K

Top Buyers

Rank Fund Capital Flow
1
M
Murchinson
Ontario, Canada
+$1.02M
2
DMKJ
David M. Knott Jr
+$1.01M
3
Jane Street
Jane Street
New York
+$855K
4
Citigroup
Citigroup
New York
+$806K
5
Russell Investments Group
Russell Investments Group
United Kingdom
+$729K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.62M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.43M
3
Wells Fargo
Wells Fargo
California
-$1.35M
4
Citadel Advisors
Citadel Advisors
Florida
-$1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$574K
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Tidal Investments
Wisconsin
$320K +$8.72K +1,388 +2%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$274K – – –
STC
28
Sarah T. Connolly
$271K – – –
BCM
29
BCK Capital Management
Connecticut
$266K – – –
Citadel Advisors
30
Citadel Advisors
Florida
$255K -$1M -159,687 -76%
MS
31
Maven Securities
Jersey
$250K -$408K -64,958 -57%
WAM
32
Wolverine Asset Management
Illinois
$240K +$281K +44,764 +2,035%
DC
33
Diametric Capital
Massachusetts
$228K +$169K +26,949 +154%
SMC
34
S. Muoio & Co
New York
$205K +$251K +40,000 New
PCM
35
PenderFund Capital Management
British Columbia, Canada
$186K +$21.3K +3,390 +15%
Northern Trust
36
Northern Trust
Illinois
$180K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$165K +$203K +32,298 New
HHGC
38
Hunting Hill Global Capital
New York
$137K +$168K +26,798 New
FFH
39
Fairfax Financial Holdings
Ontario, Canada
$125K +$153K +24,399 New
PCM
40
Prelude Capital Management
New York
$98K -$108K -17,190 -47%
Squarepoint
41
Squarepoint
New York
$96K +$117K +18,693 New
Balyasny Asset Management
42
Balyasny Asset Management
Illinois
$74K +$90.9K +14,483 New
PCA
43
Private Capital Advisors
Connecticut
$67K – – –
SAM
44
Silvercrest Asset Management
New York
$64K – – –
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
$63K -$12K -1,911 -13%
Millennium Management
46
Millennium Management
New York
$62K +$76K +12,099 New
WSFS
47
Wilmington Savings Fund Society
Delaware
$51K – – –
CC
48
Cannell Capital
Wyoming
$38K +$34.8K +5,541 +307%
Osaic Holdings
49
Osaic Holdings
Arizona
$22K -$4.53K -721 -15%
Morgan Stanley
50
Morgan Stanley
New York
$16K -$44.1K -7,027 -69%
1
2
3

FSTX Hedge Fund Activity: Q3 2022 in Review

54 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q3 2022, worth a combined $35.5M — down 21% from $45.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new FSTX positions and 11 closed out — a net gain of 2 holders — while 19 added to existing stakes and 11 trimmed.

The largest buyer was Murchinson, opening a new position worth an estimated $1.02M. The largest seller was Vanguard Group, cutting an estimated $3.62M.

  • 54 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q3 2022, up from 53 in Q2 2022.
  • Funds reported $35.5M of F-star Therapeutics, Inc. Common Stock stock for Q3 2022, down 21% quarter-over-quarter.
  • 13 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q3 2022 and 11 closed out, a net change of +2 holders.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q3 2022 was Murchinson, an estimated $1.02M added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $3.62M sold.

Based on aggregated 13F filings for Q3 2022.